User profiles for Joshua D. Wallach

Joshua D Wallach

Assistant Professor, Rollins School of Public Health
Verified email at emory.edu
Cited by 3009

Evolution of reporting P values in the biomedical literature, 1990-2015

D Chavalarias, JD Wallach, AHT Li, JPA Ioannidis - Jama, 2016 - jamanetwork.com
Importance The use and misuse ofPvalues has generated extensive debates. Objective To
evaluate in large scale thePvalues reported in the abstracts and full text of biomedical …

Reproducible research practices, transparency, and open access data in the biomedical literature, 2015–2017

JD Wallach, KW Boyack, JPA Ioannidis - PLoS biology, 2018 - journals.plos.org
Currently, there is a growing interest in ensuring the transparency and reproducibility of the
published scientific literature. According to a previous evaluation of 441 biomedical journals …

Reproducible research practices and transparency across the biomedical literature

SA Iqbal, JD Wallach, MJ Khoury, SD Schully… - PLoS …, 2016 - journals.plos.org
There is a growing movement to encourage reproducibility and transparency practices in
the scientific community, including public access to raw data and protocols, the conduct of …

Evaluation of evidence of statistical support and corroboration of subgroup claims in randomized clinical trials

JD Wallach, PG Sullivan, JF Trepanowski… - JAMA internal …, 2017 - jamanetwork.com
Importance Many published randomized clinical trials (RCTs) make claims for subgroup
differences. Objective To evaluate how often subgroup claims reported in the abstracts of RCTs …

Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses

JD Wallach, K Wang, AD Zhang, D Cheng… - bmj, 2020 - bmj.com
Objectives To conduct a systematic review and meta-analysis of the effects of rosiglitazone
treatment on cardiovascular risk and mortality using multiple data sources and varying …

Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis

JD Wallach, AC Egilman, SS Dhruva, ME McCarthy… - bmj, 2018 - bmj.com
Objectives To characterize postmarketing requirements for new drugs and biologics approved
by the US Food and Drug Administration (FDA), and to examine rates and timeliness of …

Meta-analysis comparing established risk prediction models (EuroSCORE II, STS Score, and ACEF Score) for perioperative mortality during cardiac surgery

PG Sullivan, JD Wallach, JPA Ioannidis - The American journal of …, 2016 - Elsevier
A wide variety of multivariable risk models have been developed to predict mortality in the
setting of cardiac surgery; however, the relative utility of these models is unknown. This study …

Assessment of transparency indicators across the biomedical literature: How open is open?

…, KW Boyack, N Riedel, JD Wallach… - PLoS …, 2021 - journals.plos.org
Recent concerns about the reproducibility of science have led to several calls for more open
and transparent research practices and for the monitoring of potential improvements over …

Sex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analyses

JD Wallach, PG Sullivan, JF Trepanowski… - bmj, 2016 - bmj.com
Objective To evaluate the frequency, validity, and relevance of statistically significant (P<0.05)
sex-treatment interactions in randomized controlled trials in Cochrane meta-analyses. …

Estimating the prevalence of transparency and reproducibility-related research practices in psychology (2014–2017)

…, RT Thibault, JE Kosie, JD Wallach… - Perspectives on …, 2022 - journals.sagepub.com
Psychologists are navigating an unprecedented period of introspection about the credibility
and utility of their discipline. Reform initiatives emphasize the benefits of transparency and …